Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA)-Reference-Cited by-同舟云学术

Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA)

Published:2008-03 Issue:5 Volume:314 Page:1082-1093
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Hecht Monica,von Metzler Ivana,Sack Katja,Kaiser Martin,Sezer Orhan

Publisher

Elsevier BV

Subject

Cell Biology

Reference34 articles.

1. Cancer and the microenvironment: myeloma–osteoclast interactions as a model;Yaccoby;Cancer Res.,2004

2. New potential targets for treating myeloma bone disease;Roodman;Clin. Cancer Res.,2006

3. Osteoclast differentiation and activation;Boyle;Nature,2003

4. Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo;Farrugia;Cancer Res.,2003

5. Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment;Giuliani;Blood,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features;Nature Communications;2024-02-20

2. Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA;Frontiers in Oncology;2022-05-30

3. Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes;Bone Reports;2021-12

4. Altered Fibrinolysis in Hematological Malignances;Seminars in Thrombosis and Hemostasis;2021-05-31

5. Roles of fibrinolytic factors in the alterations in bone marrow hematopoietic stem/progenitor cells during bone repair;Inflammation and Regeneration;2020-09-16